[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - The IBOVESPA index closed higher on Monday, November 23rd, amid news that the vaccine developed by Oxford University in partnership with AstraZeneca showed an average efficacy of 70% in preventing the infection of subjects, reaching up to 90% in one of the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?